As on Thursday, CAMP4 Therapeutics Corp (NASDAQ: CAMP) got off with the flyer as it spiked 22.22% to $1.98, before settling in for the price of $1.62 at the close. Taking a more long-term approach, CAMP posted a 52-week range of $1.61-$12.30.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 43.14%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 73.62%. This publicly-traded company’s shares outstanding now amounts to $20.15 million, simultaneously with a float of $2.64 million. The organization now has a market capitalization sitting at $39.92 million. At the time of writing, stock’s 50-day Moving Average stood at $4.2061.
CAMP4 Therapeutics Corp (CAMP) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. CAMP4 Therapeutics Corp’s current insider ownership accounts for 86.88%, in contrast to 13.39% institutional ownership. According to the most recent insider trade that took place on Oct 15 ’24, this organization’s 10% Owner bought 763,636 shares at the rate of 11.00, making the entire transaction reach 8,399,996 in total value, affecting insider ownership by 763,636. Preceding that transaction, on Oct 15 ’24, Company’s 10% Owner bought 727,272 for 11.00, making the whole transaction’s value amount to 7,999,992. This particular insider is now the holder of 1,579,885 in total.
CAMP4 Therapeutics Corp (CAMP) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.76 per share during the current fiscal year.
CAMP4 Therapeutics Corp’s EPS increase for this current 12-month fiscal period is 73.62% and is forecasted to reach -2.66 in the upcoming year.
CAMP4 Therapeutics Corp (NASDAQ: CAMP) Trading Performance Indicators
Let’s observe the current performance indicators for CAMP4 Therapeutics Corp (CAMP). It’s Quick Ratio in the last reported quarter now stands at 6.92. The Stock has managed to achieve an average true range (ATR) of 0.51.
Technical Analysis of CAMP4 Therapeutics Corp (CAMP)
Through scrutinizing the latest numbers posted by the [CAMP4 Therapeutics Corp, CAMP], it can be observed that its last 5-days Average volume of 71920.0 was better the volume of 46311.0, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 10.42% While, its Average True Range was 0.4752.
Raw Stochastic average of CAMP4 Therapeutics Corp (CAMP) in the period of the previous 100 days is set at 4.03%, which indicates a major fall in contrast to 13.37% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 135.21% that was lower than 194.77% volatility it exhibited in the past 100-days period.
